These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 38035072)
1. Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibody. Urai S; Watanabe M; Bando H; Motomura Y; Yamamoto M; Tachihara M; Kanzawa M; Fukuoka H; Iguchi G; Ogawa W Front Immunol; 2023; 14():1284301. PubMed ID: 38035072 [TBL] [Abstract][Full Text] [Related]
2. Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome. Kanie K; Iguchi G; Bando H; Urai S; Shichi H; Fujita Y; Matsumoto R; Suda K; Yamamoto M; Fukuoka H; Ogawa W; Takahashi Y Cancer Immunol Immunother; 2021 Dec; 70(12):3669-3677. PubMed ID: 33977343 [TBL] [Abstract][Full Text] [Related]
3. Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome. Bando H; Iguchi G; Kanie K; Nishizawa H; Matsumoto R; Fujita Y; Odake Y; Yoshida K; Suda K; Fukuoka H; Tanaka K; Ogawa W; Takahashi Y Pituitary; 2018 Oct; 21(5):480-489. PubMed ID: 30008158 [TBL] [Abstract][Full Text] [Related]
4. Autoimmune Pituitary Disease: New Concepts With Clinical Implications. Yamamoto M; Iguchi G; Bando H; Kanie K; Hidaka-Takeno R; Fukuoka H; Takahashi Y Endocr Rev; 2020 Apr; 41(2):. PubMed ID: 31513261 [TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic autoimmune hypophysitis: An emerging concept. Bando H; Kanie K; Takahashi Y Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101601. PubMed ID: 34876362 [TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome. Takahashi Y Endocr J; 2023 Jun; 70(6):559-565. PubMed ID: 37045779 [TBL] [Abstract][Full Text] [Related]
7. Isolated adrenocorticotropin deficiency associated with an autoantibody to a corticotroph antigen that is not adrenocorticotropin or other proopiomelanocortin-derived peptides. Sauter NP; Toni R; McLaughlin CD; Dyess EM; Kritzman J; Lechan RM J Clin Endocrinol Metab; 1990 May; 70(5):1391-7. PubMed ID: 2159484 [TBL] [Abstract][Full Text] [Related]
8. Acquired isolated ACTH deficiency co-occurrence with breast cancer irrespective of paraneoplastic syndrome: coincidence or inevitability. Urai S; Bando H; Nakatsuji M; Yamamoto M; Fukuoka H; Iguchi G; Ogawa W Endocrinol Diabetes Metab Case Rep; 2024 Jul; 2024(3):. PubMed ID: 39299274 [TBL] [Abstract][Full Text] [Related]
9. Clinical Heterogeneity of Acquired Idiopathic Isolated Adrenocorticotropic Hormone Deficiency. Fujita Y; Bando H; Iguchi G; Iida K; Nishizawa H; Kanie K; Yoshida K; Matsumoto R; Suda K; Fukuoka H; Ogawa W; Takahashi Y Front Endocrinol (Lausanne); 2021; 12():578802. PubMed ID: 33679614 [TBL] [Abstract][Full Text] [Related]
10. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review. Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581 [TBL] [Abstract][Full Text] [Related]
11. Why don't corticotroph tumors always produce Cushing's disease? García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379 [TBL] [Abstract][Full Text] [Related]
12. Fluctuations in plasma adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitis. Bando H; Yamamoto M; Urai S; Motomura Y; Sasaki Y; Ohmachi Y; Kobatake M; Tsujimoto Y; Oi-Yo Y; Suzuki M; Yamamoto N; Takahashi M; Fukuoka H; Iguchi G; Ogawa W J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418395 [TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review. Wang F; Shi X; Yu X; Yang Y Front Endocrinol (Lausanne); 2024; 15():1326684. PubMed ID: 38318292 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo. Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056 [TBL] [Abstract][Full Text] [Related]
15. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review. Iglesias P; Sánchez JC; Díez JJ Pituitary; 2021 Aug; 24(4):630-643. PubMed ID: 33761049 [TBL] [Abstract][Full Text] [Related]
16. The novel concept of "Onco-Immuno-Endocrinology" led to the discovery of new clinical entity "paraneoplastic autoimmune hypophysitis". Takahashi Y Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101663. PubMed ID: 35525821 [TBL] [Abstract][Full Text] [Related]
17. Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors. Kobayashi T; Iwama S; Sugiyama D; Yasuda Y; Okuji T; Ito M; Ito S; Sugiyama M; Onoue T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Nishikawa H; Arima H J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011534 [TBL] [Abstract][Full Text] [Related]
18. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review. Oğuz SH; Ünlütürk U; Aksoy S; Erbas T Immunotherapy; 2021 Oct; 13(14):1157-1163. PubMed ID: 34387129 [TBL] [Abstract][Full Text] [Related]
19. The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: A case with review of literature. Urai S; Tomofuji S; Bando H; Kanzawa M; Yamamoto M; Fukuoka H; Tsuda M; Iguchi G; Ogawa W J Neuroendocrinol; 2024 Jun; 36(6):e13395. PubMed ID: 38631695 [TBL] [Abstract][Full Text] [Related]